Chemomab Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
/PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of...
Source: prnewswire.com